FPR2 agonists (Actelion Pharmaceuticals)

N/A

Report date: 2025/03/20 15:16:31
NME

Base Information

Drug NameFPR2 agonists (Actelion Pharmaceuticals)
Drug Alias Nameformyl peptide receptor 2 agonists (Actelion Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN-formyl peptide receptor 2 inhibitors
TargetsN-formyl peptide receptor 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesActelion Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A